MedTrace Logo

The Study of Soy Isoflavones in Asthma

NCT01052116 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 386

Last updated 2016-01-14

Study results available
· View outcomes & findings →

Summary

The trial is designed to study the effects of soy supplements on asthma control.

Conditions

Interventions

DRUG

Soy isoflavone supplement

Oral soy isoflavone supplement (100 mg/day)

DRUG

Placebo

Placebo

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • American Lung Association Asthma Clinical Research Centers

    lead OTHER

Principal Investigators

  • Lewis J Smith, MD · Northwestern University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2012-08-31
Completion
2012-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01052116 on ClinicalTrials.gov